0:00 / 0:00
Regulation of growth by the mTOR pathway
NIH VideoCast
47K subscribers • 38 videos on Rounds • Health institution
- Published by NIH VideoCast, one of the health institutions Rounds lists. Nobody has recommended it in the communities yet, so it ranks below community picks.
- Presented by David M. Sabatini, M.D., Ph.D., as the video describes them
- May be out of date. Uploaded 13 years ago, in an area where guidance changes.
Aimed at clinicians, students or researchers. Education, not medical advice.
68K views13 years ago
Aging and longevityHeart and metabolismMetabolism and energyBiology of agingCancer biology
David M. Sabatini, M.D., Ph.D. explains how the mTOR pathway regulates cell growth, metabolism, and aging through distinct protein complexes.
Regulation of growth by the mTOR pathway Air date: Wednesday, March 20, 2013, PM Wednesday Afternoon Lecture Series The mammalian target of rapamycin (mTOR), the target of the immunosuppressive drug rapamycin, is the central component of a nutrient- and hormone-sensitive signaling pathway that regulates cell growth and proliferation. This pathway becomes deregulated in many human cancers and plays an important role in the control of metabolism and aging. Sabatini's lab has identified two distinct mTOR-containing proteins complexes, one of which regulates growth through S6K and another that regulates cell survival through Akt. These complexes, mTORC1 and mTORC2, define both rapamycin-sensitive and insensitive branches of the mTOR pathway. New results on the regulation and functions of the mTORC1 and mTORC2 pathways will be discussed. Author: David M. Sabatini, M.D., Ph.D., MIT Runtime: Permanent link: videocast.nih.gov/launch.asp?17962Why it's here
From a health institutionNIH VideoCast is on Rounds' list of health institutions, and this upload is one of its most-watched lectures or explainers. Nobody has recommended it in the communities yet, so it ranks below community picks.